← Open Payments lookup

BENJAMIN LLOYD: Open Payments

NPI 1013557941 · OMAHA, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,596 in 89 payments from 19 companies in 2025. Trend: 2023 $59 · 2024 $284 · 2025 $1,596

Food & beverage: $1,596
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP10$337
Grifols USA, LLC13$219
Avadel CNS Pharmaceuticals, LLC14$196
Insmed, Inc.12$171
Verona Pharma, Inc.4$87
Electromed, Inc.6$65
GENZYME CORPORATION4$64
Regeneron Healthcare Solutions, Inc.4$64
Actelion Pharmaceuticals US, Inc.4$63
Takeda Pharmaceuticals U.S.A., Inc.2$56

Products named: FASENRA, Prolastin-C Liquid, LUMRYZ, Arikayce, DUPIXENT, Ohtuvayre, SMARTVEST, OPSYNVI.

Industry payments across NE — which companies pay providers there.